+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Ocular Implants Market by Product Type, Application, Technology, Material, End Users, Distribution Channels - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715896
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Ocular Implants Market grew from USD 14.57 billion in 2024 to USD 15.55 billion in 2025. It is expected to continue growing at a CAGR of 6.46%, reaching USD 21.23 billion by 2030.

Exploring the Rise of Ocular Implant Solutions

Vision impairment continues to challenge healthcare systems and patient quality of life worldwide, driving an urgent need for advanced ocular solutions. Ocular implants have emerged as a transformative lifeline, offering precise visual restoration for conditions ranging from cataracts to severe retinal disorders. These devices leverage cutting-edge biomaterials and microsurgical techniques to address complex ocular pathologies in both adult and pediatric populations.

Recent advancements in implant design and manufacturing have accelerated the transition from experimental prototypes to mainstream clinical adoption. Manufacturers are investing heavily in research to improve biocompatibility, reduce post-operative complications, and enhance long-term visual outcomes. Amid an aging global population and rising prevalence of chronic eye diseases, the ocular implant sector stands at the forefront of medical device innovation.

This executive summary distills the most critical market developments, from evolving regulatory frameworks to key driver analysis. By synthesizing transformative shifts, tariff impacts, segmentation dynamics, and strategic recommendations, this overview equips stakeholders with a concise yet comprehensive roadmap to navigate the ocular implant landscape and capitalize on emerging opportunities.

Transforming the Ocular Implantation Landscape

The ocular implant market is undergoing a profound transformation driven by technological breakthroughs that redefine surgical precision and patient experience. Next-generation intraocular lenses now incorporate accommodating and extended depth of focus architectures, delivering superior postoperative visual acuity across multiple focal points. Simultaneously, microinvasive glaucoma surgery devices and advanced corneal implants are reshaping procedural protocols and recovery timelines.

Regulators and payers are responding to these innovations by streamlining approval pathways and adapting reimbursement models. Standards bodies have introduced accelerated review mechanisms for breakthrough ocular devices, while healthcare systems are piloting value-based contracting to align reimbursements with clinical outcomes. Parallel to these shifts, digital health platforms are enabling remote monitoring of implant performance and patient adherence, fostering a more integrated continuum of care.

Collaborative partnerships are also proliferating, connecting ophthalmic surgeons, device manufacturers, and technology firms. Data-driven insights from intraoperative imaging and artificial intelligence are informing the next wave of implant designs. In addition, emerging bioprinting techniques hold promise for custom-tailored prostheses, further blurring the line between medical device and regenerative medicine. Together, these forces are setting a new benchmark for efficacy, safety, and patient-centricity in ocular implantation.

Assessing the Impact of 2025 US Tariffs on Ocular Implants

The introduction of heightened United States tariffs on medical imports in 2025 has triggered ripple effects across the ocular implant value chain. Critical raw materials such as medical-grade silicone, polymethyl methacrylate, and specialized collagen polymers now face elevated duties, inflating production costs for manufacturers. These cost pressures threaten to erode profit margins and, unless managed strategically, could translate into higher pricing for healthcare providers and patients.

Suppliers have encountered logistical bottlenecks as they grapple with restructured trade flows and customs compliance requirements. Extended lead times for imported components have led manufacturers to reevaluate supplier portfolios and explore near-shoring opportunities. Concurrently, device makers are reassessing pricing strategies and contract terms with hospital groups, seeking to preserve volume while protecting margin integrity.

Industry associations have mobilized advocacy efforts to mitigate the most burdensome tariff provisions and negotiate targeted exemptions for critical ophthalmic materials. Meanwhile, forward-looking organizations are diversifying upstream partnerships and investing in localized manufacturing hubs to enhance supply chain resilience. By proactively adapting their sourcing and production frameworks, market leaders aim to cushion the impact of tariffs and safeguard continuous innovation.

Diving Deep into Market Segmentation Dynamics

A nuanced understanding of product type segmentation reveals varied growth dynamics across the ocular implant spectrum. Corneal implants and scleral buckles continue to address niche clinical indications, while overarching momentum concentrates on intraocular lenses powered by accommodating, extended depth of focus, monofocal, multifocal and toric optics. Glaucoma drainage devices and retinal prostheses, though less prevalent, attract substantial R&D investment given their potential to transform chronic disease management and severe vision loss therapies.

Application-based segmentation highlights a broad therapeutic canvas. Cataract surgery remains the primary revenue driver, yet glaucoma treatment through both drainage devices and micro invasive glaucoma surgery is witnessing rapid proliferation. Keratoconus correction solutions fulfill a growing need among younger patients, and ocular trauma repair devices, along with bespoke interventions for retinal disorders, are gaining prominence in specialized clinical centers.

Technological differentiation underscores the competitive importance of lens designs that deliver true accommodative response and enhanced depth of focus. The supporting material landscape spans acrylic, collagen, hydrogel, PMMA, and silicone, each offering distinct biocompatibility and mechanical properties that influence surgical technique and postoperative outcomes. Distribution channels range across direct tendering, traditional distributors and emerging online platforms, while end users including ambulatory surgical centers, hospitals, ophthalmic centers and specialty clinics navigate these channels in alignment with procurement policies and care models.

Unraveling Regional Market Distinctions

Regional market characteristics diverge significantly across the Americas, Europe, Middle East & Africa and Asia-Pacific. In the Americas, mature healthcare infrastructure and favorable reimbursement frameworks underpin robust adoption of premium intraocular lenses and advanced glaucoma devices. The United States market in particular exhibits strong demand for toric and multifocal designs, complemented by nationwide deployment of ambulatory surgical centers that streamline outpatient procedures.

In Europe, Middle East & Africa, regulatory harmonization within the European Union facilitates cross-border product launches, though individual country reimbursement landscapes vary widely. Northern European markets emphasize patient-reported outcome measures, while Middle Eastern healthcare hubs invest heavily in cutting-edge retinal prosthesis trials. Sub-Saharan Africa still contends with basic access challenges but shows early uptake of lower-cost hydrogel and silicone-based implants.

Asia-Pacific emerges as the fastest evolving region, driven by expanding hospital networks in China and India, rising prevalence of diabetic retinopathy and cataract burdens, and governmental initiatives to improve rural ophthalmic services. Local manufacturers are scaling production of intraocular lenses and corneal devices, while international players forge joint ventures to tap into these high-growth markets. Teleophthalmology and mobile surgical units are also gaining traction as innovative delivery models in diverse geographies.

Profiling Leading Ocular Implant Innovators

Major global players continue to define the competitive landscape through extensive product portfolios and deep clinical partnerships. Established device manufacturers maintain leadership in intraocular lens technology, leveraging decades of clinical data and surgeon preference. They reinforce their positions with continuous enhancements to accommodating and extended depth of focus optics, supported by robust distribution networks spanning hospitals and ambulatory surgical centers.

Specialized technology firms claim niches in glaucoma and retinal solutions. Their strategies often center on high-impact innovation, such as microinvasive glaucoma surgery platforms and next-generation retinal prostheses. By collaborating with academic research centers and securing regulatory fast-track designations, these companies accelerate time-to-market and cultivate clinician loyalty in key ophthalmic departments.

An emerging cohort of agile innovators and biotech startups is challenging incumbents with disruptive materials and digital integration. Partnerships between device developers and telemedicine providers are driving remote monitoring capabilities, while alliances with contract manufacturers are expanding production flexibility. Strategic mergers and acquisitions further position some mid-tier companies to scale rapidly, diversify their portfolios, and meet the growing demand for personalized vision solutions.

Driving Strategic Actions for Industry Leadership

Industry leaders should prioritize investment in next-generation intraocular lens research, with a particular focus on accommodating mechanisms and extended depth of focus architectures. Reinforcing material science innovation across acrylic, collagen, hydrogel and silicone composites will enhance biocompatibility and reduce adverse events, securing clinician and patient confidence.

To counteract tariff-related cost pressures, supply chain strategies must evolve. Securing alternative material sources through regional partnerships and expanding localized manufacturing capacities will mitigate import duties and transportation bottlenecks. Streamlining logistics and implementing vendor-managed inventory systems can further optimize operational efficiency.

Embracing digital health integration will unlock new value propositions. By coupling implantable technologies with remote diagnostic tools and patient engagement platforms, organizations can deliver enhanced postoperative monitoring and data-driven care. Developing interoperable software ecosystems will support personalized treatment regimens and strengthen long-term patient adherence.

Finally, expanding into underpenetrated geographic markets through joint ventures and licensing agreements will broaden revenue streams. Tailoring portfolio offerings to local clinical needs and reimbursement realities ensures market receptivity. Cultivating strong relationships with regional key opinion leaders and regulatory bodies will accelerate product adoption and maintain competitive advantage.

Detailing the Research Framework and Approach

This analysis draws on a rigorous blend of secondary and primary research methodologies to ensure depth and precision. Extensive review of scientific literature, regulatory filings, patent databases and company financial disclosures provided foundational context on existing technologies, market trends and competitive positioning.

Primary research included structured interviews with ophthalmic surgeons, healthcare administrators, supply chain experts and industry analysts. These discussions yielded qualitative insights into clinical adoption drivers, procurement dynamics and surgeon preferences. A targeted survey of implant manufacturers further quantified strategic priorities and R&D trajectories.

Data triangulation and validation were conducted through an expert advisory panel comprising leading clinicians, academic researchers and regulatory consultants. Their collective review of preliminary findings enhanced the robustness of conclusions and ensured alignment with frontline market realities. This comprehensive framework delivers a balanced and authoritative perspective on the ocular implant ecosystem.

Concluding Insights on Ocular Implant Market Evolution

The ocular implant field stands at an inflection point, shaped by converging technological, economic and regulatory forces. Advanced lens designs, microinvasive surgery platforms and digital health tools are expanding the horizons of vision restoration, while tariff dynamics and shifting distribution models present both challenges and opportunities.

In synthesizing these multifaceted developments, stakeholders gain a clear roadmap to navigate competitive pressures and evolving patient needs. This executive summary highlights the critical levers for growth, enabling manufacturers, care providers and investors to align strategies with emerging market realities.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Corneal Implant
    • Glaucoma Drainage Device
    • Intraocular Lens
      • Accommodating
      • Extended Depth Of Focus
      • Monofocal
      • Multifocal
      • Toric
    • Retinal Prosthesis
    • Scleral Buckle
  • Application
    • Cataract Surgery
    • Glaucoma Treatment
      • Glaucoma Drainage Device
      • Micro Invasive Glaucoma Surgery
    • Keratoconus Correction
    • Ocular Trauma Repair
    • Retinal Disorders
  • Technology
    • Accommodating
    • Extended Depth Of Focus
    • Monofocal
    • Multifocal
    • Toric
  • Material
    • Acrylic
    • Collagen
    • Hydrogel
    • PMMA
    • Silicone
  • End Users
    • Ambulatory Surgical Centers
    • Hospitals
    • Ophthalmic Centers
    • Specialty Clinics
  • Distribution Channels
    • Direct Tendering
    • Distributor
    • Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Alcon Inc.
  • Johnson & Johnson Vision Care, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • HOYA Corporation
  • STAAR Surgical Company
  • Rayner Intraocular Lenses Limited
  • PhysIOL SA
  • Lenstec, Inc.
  • Domilens SA

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Ocular Implants Market, by Product Type
8.1. Introduction
8.2. Corneal Implant
8.3. Glaucoma Drainage Device
8.4. Intraocular Lens
8.4.1. Accommodating
8.4.2. Extended Depth of Focus
8.4.3. Monofocal
8.4.4. Multifocal
8.4.5. Toric
8.5. Retinal Prosthesis
8.6. Scleral Buckle
9. Ocular Implants Market, by Application
9.1. Introduction
9.2. Cataract Surgery
9.3. Glaucoma Treatment
9.3.1. Glaucoma Drainage Device
9.3.2. Micro Invasive Glaucoma Surgery
9.4. Keratoconus Correction
9.5. Ocular Trauma Repair
9.6. Retinal Disorders
10. Ocular Implants Market, by Technology
10.1. Introduction
10.2. Accommodating
10.3. Extended Depth of Focus
10.4. Monofocal
10.5. Multifocal
10.6. Toric
11. Ocular Implants Market, by Material
11.1. Introduction
11.2. Acrylic
11.3. Collagen
11.4. Hydrogel
11.5. PMMA
11.6. Silicone
12. Ocular Implants Market, by End Users
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
12.4. Ophthalmic Centers
12.5. Specialty Clinics
13. Ocular Implants Market, by Distribution Channels
13.1. Introduction
13.2. Direct Tendering
13.3. Distributor
13.4. Online
14. Americas Ocular Implants Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Ocular Implants Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Ocular Implants Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Alcon Inc.
17.3.2. Johnson & Johnson Vision Care, Inc.
17.3.3. Bausch & Lomb Incorporated
17.3.4. Carl Zeiss Meditec AG
17.3.5. HOYA Corporation
17.3.6. STAAR Surgical Company
17.3.7. Rayner Intraocular Lenses Limited
17.3.8. PhysIOL SA
17.3.9. Lenstec, Inc.
17.3.10. Domilens SA
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. OCULAR IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. OCULAR IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. OCULAR IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL OCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. OCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. OCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. OCULAR IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY CORNEAL IMPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY ACCOMMODATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY EXTENDED DEPTH OF FOCUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY MONOFOCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY MULTIFOCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY TORIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY RETINAL PROSTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY SCLERAL BUCKLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY MICRO INVASIVE GLAUCOMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY KERATOCONUS CORRECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY OCULAR TRAUMA REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY ACCOMMODATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY EXTENDED DEPTH OF FOCUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY MONOFOCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY MULTIFOCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY TORIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY ACRYLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY PMMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY OPHTHALMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY DIRECT TENDERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL OCULAR IMPLANTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES OCULAR IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 68. CANADA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. CANADA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. CANADA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 72. CANADA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 73. CANADA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 78. MEXICO OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 115. GERMANY OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. GERMANY OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 117. GERMANY OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. GERMANY OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. GERMANY OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. GERMANY OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 123. FRANCE OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 125. FRANCE OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 127. FRANCE OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. FRANCE OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 129. FRANCE OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 130. FRANCE OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 139. ITALY OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. ITALY OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 141. ITALY OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. ITALY OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. ITALY OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. ITALY OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 145. ITALY OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 146. ITALY OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 147. SPAIN OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. SPAIN OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 149. SPAIN OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. SPAIN OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 151. SPAIN OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. SPAIN OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 153. SPAIN OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 154. SPAIN OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 179. DENMARK OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. DENMARK OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 181. DENMARK OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. DENMARK OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. DENMARK OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 185. DENMARK OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 186. DENMARK OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. NETHERLANDS OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 195. QATAR OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. QATAR OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 197. QATAR OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. QATAR OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 199. QATAR OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. QATAR OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. QATAR OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 202. QATAR OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 203. FINLAND OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. FINLAND OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 205. FINLAND OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. FINLAND OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 207. FINLAND OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. FINLAND OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 209. FINLAND OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 210. FINLAND OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. NIGERIA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 223. NIGERIA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. NIGERIA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 225. NIGERIA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 226. NIGERIA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 227. EGYPT OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. EGYPT OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 229. EGYPT OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. EGYPT OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 231. EGYPT OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. EGYPT OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 233. EGYPT OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 234. EGYPT OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 235. TURKEY OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. TURKEY OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 237. TURKEY OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. TURKEY OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 239. TURKEY OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. TURKEY OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 241. TURKEY OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 242. TURKEY OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 251. NORWAY OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. NORWAY OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 253. NORWAY OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. NORWAY OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 255. NORWAY OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. NORWAY OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 257. NORWAY OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 258. NORWAY OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 259. POLAND OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. POLAND OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 261. POLAND OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. POLAND OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 263. POLAND OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. POLAND OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 265. POLAND OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 266. POLAND OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 273. SWITZERLAND OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 274. SWITZERLAND OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC OCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 284. CHINA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. CHINA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 286. CHINA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. CHINA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 288. CHINA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. CHINA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 290. CHINA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 291. CHINA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 292. INDIA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. INDIA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 294. INDIA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. INDIA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 296. INDIA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. INDIA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 298. INDIA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 299. INDIA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 300. JAPAN OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. JAPAN OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 302. JAPAN OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. JAPAN OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 304. JAPAN OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. JAPAN OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 306. JAPAN OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 307. JAPAN OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 314. AUSTRALIA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 315. AUSTRALIA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. SOUTH KOREA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 322. SOUTH KOREA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 323. SOUTH KOREA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. INDONESIA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 326. INDONESIA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. INDONESIA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 328. INDONESIA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 329. INDONESIA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 330. INDONESIA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 331. INDONESIA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 332. THAILAND OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. THAILAND OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 334. THAILAND OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. THAILAND OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 336. THAILAND OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 337. THAILAND OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 338. THAILAND OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 339. THAILAND OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 341. PHILIPPINES OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 342. PHILIPPINES OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. PHILIPPINES OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 344. PHILIPPINES OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 345. PHILIPPINES OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 346. PHILIPPINES OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 347. PHILIPPINES OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 348. MALAYSIA OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 349. MALAYSIA OCULAR IMPLANTS MARKET SIZE, BY INTRAOCULAR LENS, 2018-2030 (USD MILLION)
TABLE 350. MALAYSIA OCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 351. MALAYSIA OCULAR IMPLANTS MARKET SIZE, BY GLAUCOMA TREATMENT, 2018-2030 (USD MILLION)
TABLE 352. MALAYSIA OCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 353. MALAYSIA OCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 354. MALAYSIA OCULAR IMPLANTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 355. MALAYSIA OCULAR IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 356. SINGAPORE OCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Ocular Implants market report include:
  • Alcon Inc.
  • Johnson & Johnson Vision Care, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • HOYA Corporation
  • STAAR Surgical Company
  • Rayner Intraocular Lenses Limited
  • PhysIOL SA
  • Lenstec, Inc.
  • Domilens SA

Table Information